CN116440245A - Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application - Google Patents
Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application Download PDFInfo
- Publication number
- CN116440245A CN116440245A CN202310536971.7A CN202310536971A CN116440245A CN 116440245 A CN116440245 A CN 116440245A CN 202310536971 A CN202310536971 A CN 202310536971A CN 116440245 A CN116440245 A CN 116440245A
- Authority
- CN
- China
- Prior art keywords
- parts
- weight
- chinese medicine
- traditional chinese
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 89
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 230000002401 inhibitory effect Effects 0.000 title claims abstract description 16
- 208000037883 airway inflammation Diseases 0.000 title abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 13
- 206010068956 Respiratory tract inflammation Diseases 0.000 claims abstract description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 210000004369 blood Anatomy 0.000 claims description 22
- 239000008280 blood Substances 0.000 claims description 22
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 22
- 241000282994 Cervidae Species 0.000 claims description 19
- 206010061218 Inflammation Diseases 0.000 claims description 19
- 230000004054 inflammatory process Effects 0.000 claims description 19
- 239000000843 powder Substances 0.000 claims description 19
- 108010010803 Gelatin Proteins 0.000 claims description 18
- 239000008273 gelatin Substances 0.000 claims description 18
- 229920000159 gelatin Polymers 0.000 claims description 18
- 235000019322 gelatine Nutrition 0.000 claims description 18
- 235000011852 gelatine desserts Nutrition 0.000 claims description 18
- 210000003899 penis Anatomy 0.000 claims description 17
- 241000756042 Polygonatum Species 0.000 claims description 15
- 241001145025 Saussurea involucrata Species 0.000 claims description 14
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 13
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 13
- 241000234435 Lilium Species 0.000 claims description 13
- 241000361919 Metaphire sieboldi Species 0.000 claims description 13
- 244000268590 Euryale ferox Species 0.000 claims description 12
- 235000010469 Glycine max Nutrition 0.000 claims description 12
- 244000068988 Glycine max Species 0.000 claims description 12
- 235000009122 Rubus idaeus Nutrition 0.000 claims description 12
- 241000121220 Tricholoma matsutake Species 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 12
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 11
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 11
- 241000251511 Holothuroidea Species 0.000 claims description 11
- 235000008708 Morus alba Nutrition 0.000 claims description 11
- 240000000249 Morus alba Species 0.000 claims description 11
- 235000008737 Polygonatum biflorum Nutrition 0.000 claims description 11
- 235000011034 Rubus glaucus Nutrition 0.000 claims description 11
- 240000001417 Vigna umbellata Species 0.000 claims description 11
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 10
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 10
- 235000018457 Gynura procumbens Nutrition 0.000 claims description 10
- 240000008672 Gynura procumbens Species 0.000 claims description 10
- 240000007049 Juglans regia Species 0.000 claims description 10
- 235000009496 Juglans regia Nutrition 0.000 claims description 10
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 10
- 244000179886 Moringa oleifera Species 0.000 claims description 10
- 235000014676 Phragmites communis Nutrition 0.000 claims description 10
- 244000046146 Pueraria lobata Species 0.000 claims description 10
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 10
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 10
- 235000020234 walnut Nutrition 0.000 claims description 10
- 244000025254 Cannabis sativa Species 0.000 claims description 9
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 9
- 235000009421 Myristica fragrans Nutrition 0.000 claims description 9
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 235000017803 cinnamon Nutrition 0.000 claims description 9
- 235000008434 ginseng Nutrition 0.000 claims description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 9
- 235000011477 liquorice Nutrition 0.000 claims description 9
- 108010070324 lumbrokinase Proteins 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 8
- 235000006487 Euryale ferox Nutrition 0.000 claims description 8
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 8
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 8
- 244000197580 Poria cocos Species 0.000 claims description 8
- 235000008599 Poria cocos Nutrition 0.000 claims description 8
- 244000309464 bull Species 0.000 claims description 8
- 239000003527 fibrinolytic agent Substances 0.000 claims description 8
- 230000003480 fibrinolytic effect Effects 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- 239000001702 nutmeg Substances 0.000 claims description 8
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 7
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 7
- 240000002624 Mespilus germanica Species 0.000 claims description 7
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 7
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 7
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 7
- 108091006088 activator proteins Proteins 0.000 claims description 7
- 235000009120 camo Nutrition 0.000 claims description 7
- 235000005607 chanvre indien Nutrition 0.000 claims description 7
- 239000011487 hemp Substances 0.000 claims description 7
- 241000572565 Alpinia oxyphylla Species 0.000 claims description 6
- 235000012907 honey Nutrition 0.000 claims description 6
- 241001529821 Agastache Species 0.000 claims description 5
- 240000004510 Agastache rugosa Species 0.000 claims description 5
- 235000013421 Kaempferia galanga Nutrition 0.000 claims description 5
- 244000062241 Kaempferia galanga Species 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 244000270834 Myristica fragrans Species 0.000 claims description 4
- 241001162994 Rugosus Species 0.000 claims description 4
- 230000003097 anti-respiratory effect Effects 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 235000001188 Peltandra virginica Nutrition 0.000 claims description 3
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 3
- 244000273928 Zingiber officinale Species 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims description 3
- 235000008397 ginger Nutrition 0.000 claims description 3
- 240000000171 Crataegus monogyna Species 0.000 claims 2
- 240000004371 Panax ginseng Species 0.000 claims 2
- 240000007651 Rubus glaucus Species 0.000 claims 2
- 241000724115 Ziziphus lotus Species 0.000 claims 2
- 241000218236 Cannabis Species 0.000 claims 1
- 206010011224 Cough Diseases 0.000 abstract description 33
- 208000031971 Yin Deficiency Diseases 0.000 abstract description 14
- 208000013116 chronic cough Diseases 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 8
- 230000033228 biological regulation Effects 0.000 abstract description 4
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 39
- 241000699670 Mus sp. Species 0.000 description 26
- 210000004072 lung Anatomy 0.000 description 26
- 235000013399 edible fruits Nutrition 0.000 description 21
- 210000000952 spleen Anatomy 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 20
- 241000196324 Embryophyta Species 0.000 description 18
- 206010062717 Increased upper airway secretion Diseases 0.000 description 17
- 208000026435 phlegm Diseases 0.000 description 17
- 239000002552 dosage form Substances 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 14
- 206010012735 Diarrhoea Diseases 0.000 description 13
- 244000235659 Rubus idaeus Species 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 102000004889 Interleukin-6 Human genes 0.000 description 12
- 108090001005 Interleukin-6 Proteins 0.000 description 12
- 240000004308 marijuana Species 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 102000013691 Interleukin-17 Human genes 0.000 description 11
- 230000007812 deficiency Effects 0.000 description 11
- 230000002757 inflammatory effect Effects 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 208000011580 syndromic disease Diseases 0.000 description 10
- 102000008186 Collagen Human genes 0.000 description 9
- 108010035532 Collagen Proteins 0.000 description 9
- 241000243684 Lumbricus Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 229920001436 collagen Polymers 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 210000003979 eosinophil Anatomy 0.000 description 8
- 210000004185 liver Anatomy 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 241001092040 Crataegus Species 0.000 description 7
- 240000002853 Nelumbo nucifera Species 0.000 description 7
- 240000005373 Panax quinquefolius Species 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 210000000265 leukocyte Anatomy 0.000 description 7
- 210000004698 lymphocyte Anatomy 0.000 description 7
- 244000052769 pathogen Species 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 239000002689 soil Substances 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 7
- 241000498779 Myristica Species 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 206010047700 Vomiting Diseases 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 210000000440 neutrophil Anatomy 0.000 description 6
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 206010041497 Spermatorrhoea Diseases 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 208000006673 asthma Diseases 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000008216 herbs Nutrition 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 210000001550 testis Anatomy 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 241000283007 Cervus nippon Species 0.000 description 4
- 102000029816 Collagenase Human genes 0.000 description 4
- 108060005980 Collagenase Proteins 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000003123 bronchiole Anatomy 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 229960002424 collagenase Drugs 0.000 description 4
- 230000000875 corresponding effect Effects 0.000 description 4
- 230000028709 inflammatory response Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 238000007619 statistical method Methods 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 240000002234 Allium sativum Species 0.000 description 3
- 206010006458 Bronchitis chronic Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010008479 Chest Pain Diseases 0.000 description 3
- 244000183685 Citrus aurantium Species 0.000 description 3
- 235000007716 Citrus aurantium Nutrition 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010013954 Dysphoria Diseases 0.000 description 3
- 108010049003 Fibrinogen Proteins 0.000 description 3
- 102000008946 Fibrinogen Human genes 0.000 description 3
- 241001633680 Polygonatum odoratum Species 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 241000234299 Zingiberaceae Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000000621 bronchi Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 208000007451 chronic bronchitis Diseases 0.000 description 3
- 235000008504 concentrate Nutrition 0.000 description 3
- 229940012952 fibrinogen Drugs 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000004611 garlic Nutrition 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 238000010172 mouse model Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000021251 pulses Nutrition 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010074051 C-Reactive Protein Proteins 0.000 description 2
- 102100032752 C-reactive protein Human genes 0.000 description 2
- 241000606161 Chlamydia Species 0.000 description 2
- 241001573881 Corolla Species 0.000 description 2
- 206010014561 Emphysema Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 241000229143 Hippophae Species 0.000 description 2
- 235000003935 Hippophae Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000589248 Legionella Species 0.000 description 2
- 208000007764 Legionnaires' Disease Diseases 0.000 description 2
- 241000234280 Liliaceae Species 0.000 description 2
- 244000241838 Lycium barbarum Species 0.000 description 2
- 235000015459 Lycium barbarum Nutrition 0.000 description 2
- 241000218231 Moraceae Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000204031 Mycoplasma Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- -1 PH regulators Substances 0.000 description 2
- 241000233872 Pneumocystis carinii Species 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 241000606701 Rickettsia Species 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 229940097217 cardiac glycoside Drugs 0.000 description 2
- 239000002368 cardiac glycoside Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 102000013373 fibrillar collagen Human genes 0.000 description 2
- 108060002894 fibrillar collagen Proteins 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000008297 liquid dosage form Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000006186 oral dosage form Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000006201 parenteral dosage form Substances 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000010686 Agastache rugosa Nutrition 0.000 description 1
- 208000036065 Airway Remodeling Diseases 0.000 description 1
- 235000018645 Allium odorum Nutrition 0.000 description 1
- 240000008654 Allium ramosum Species 0.000 description 1
- 235000005338 Allium tuberosum Nutrition 0.000 description 1
- 241000013298 Alpinia <beetle> Species 0.000 description 1
- 244000141218 Alpinia officinarum Species 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 244000141331 Amomum villosum Species 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000993291 Armillariella Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 241000596154 Belamcanda Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000008697 Cannabis sativa Nutrition 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 206010008796 Chromaturia Diseases 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 241000723347 Cinnamomum Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 244000016281 Cymbalaria muralis Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000258955 Echinodermata Species 0.000 description 1
- 241000218671 Ephedra Species 0.000 description 1
- 241000283087 Equus Species 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 240000004272 Eragrostis cilianensis Species 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010088842 Fibrinolysin Proteins 0.000 description 1
- 235000016970 Fragaria moschata Nutrition 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000014828 Fragaria vesca ssp. americana Nutrition 0.000 description 1
- 235000012660 Fragaria virginiana Nutrition 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 241001558017 Gynura Species 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 235000015916 Hydrocotyle vulgaris Nutrition 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021518 Impaired gastric emptying Diseases 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241001656771 Lilium bulbiferum Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000005041 Mylar™ Substances 0.000 description 1
- 241001081833 Myristicaceae Species 0.000 description 1
- 206010052319 Nasal flaring Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 238000010220 Pearson correlation analysis Methods 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000218093 Phedimus aizoon Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 241000037831 Polygonatum sibiricum Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 1
- 241000219100 Rhamnaceae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 235000014548 Rubus moluccanus Nutrition 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108700028909 Serum Amyloid A Proteins 0.000 description 1
- 102000054727 Serum Amyloid A Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 244000234181 Syzygium samarangense Species 0.000 description 1
- 235000012096 Syzygium samarangense Nutrition 0.000 description 1
- 241000223257 Thermomyces Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000222433 Tricholomataceae Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 206010047924 Wheezing Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000036428 airway hyperreactivity Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000000924 antiasthmatic agent Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000000702 aorta abdominal Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000000546 chi-square test Methods 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 description 1
- 229960001117 clenbuterol Drugs 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 208000024389 cytopenia Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 208000001288 gastroparesis Diseases 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 208000018997 giddiness Diseases 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 125000001474 phenylpropanoid group Chemical group 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 210000001938 protoplast Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 1
- 229960003147 reserpine Drugs 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 1
- 235000019643 salty taste Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 235000019654 spicy taste Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8967—Lilium, e.g. tiger lily or Easter lily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9062—Alpinia, e.g. red ginger or galangal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Insects & Arthropods (AREA)
- Animal Husbandry (AREA)
- Reproductive Health (AREA)
- Marine Sciences & Fisheries (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for inhibiting airway inflammation, a preparation method and application thereof. The traditional Chinese medicine composition for inhibiting respiratory tract inflammation is prepared by adopting up to 37-40 traditional Chinese medicine raw materials, comprehensively playing the medicinal components of various components and flexibly matching. The traditional Chinese medicine composition provided by the invention can control cough through a method of inhibiting airway inflammation through reasonable formula of special medicinal materials and dialectical regulation, and confirms that the pathogenesis of chronic cough with lung-yin deficiency in traditional Chinese medicine is related to airway inflammation.
Description
Technical Field
The invention relates to the technical field of anti-respiratory disease medicines of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for inhibiting respiratory inflammation, a preparation method and application thereof.
Background
Inflammation of the respiratory system is classified into acute and chronic according to the duration of the disease, wherein chronic bronchitis is commonly seen in middle-aged and elderly people, and is also called "old and slow bronchitis". The chronic bronchitis has high incidence rate and repeated illness, can be complicated with obstructive emphysema, even pulmonary arterial hypertension and pulmonary heart disease, and seriously affects the life and work of patients. If the respiratory system is infected repeatedly, the obstructive emphysema is often caused, and a few patients can be complicated with bronchiectasis. Respiratory inflammation belongs to the categories of cough, phlegm retention, cough asthma and the like in traditional Chinese medicine. Invasion of exogenous pathogens and dysfunction of the lung, spleen and kidney are considered to be the main causes of this disease. The body's healthy qi is deficient, the defensive exterior is lost, and the exogenous pathogenic factors are felt, which can be pathogenic wind-cold, pathogenic wind-heat, pathogenic wind-cold transforming into heat and invading the lung to cause the lung to lose dispersing and descending; or weak lung qi, unconsolidation of defensive exterior, and repeated feeling of exogenous pathogenic factors; or spleen qi deficiency and spleen qi deficiency, spleen failing to transport and transform, dampness accumulating into phlegm and stopping accumulating in the lung due to the old and weak body; or lung with a hangover, a complex feeling of exogenous pathogenic factors; or after a long time of illness, the spleen and lung damage and kidney cause kidney qi deficiency and qi receiving inadequacy.
The traditional Chinese medicines are various in variety and different in compatibility, the effects of treating chronic bronchitis are different, for example, the angelica is six yellow Shang Ke, the yin and yang balance of the organism is regulated, the immunity of the organism is improved and enhanced, the treatment rate is improved, and adverse reactions are avoided; the Hui Gui Zhu Gan Tang is mainly used for treating phlegm-fluid retention under the heart, and chest and hypochondrium fullness and distention, which is the disease of phlegm-fluid retention; the modified mulberry bark decoction has the functions of clearing heat, resolving phlegm, and dispersing lung and relieving asthma; cough and asthma caused by belamcanda rhizome and ephedra Shang Zhuzhi can not be recumbent, the whistle between the throats is like watery chicken voice, the phlegm is thin and white, the thirsty drink is not caused, the coating is white, the pulse is wiry and tight, and the like; perilla seed decoction for lowering qi can reduce qi and resolve phlegm, so that asthma and cough can be relieved; xuan Bai decoction for dispersing lung qi, dredging viscera, treating viscera simultaneously, and restoring qi movement, can eliminate cough, dyspnea, and constipation; the five-flavor seabuckthorn powder is a proved recipe of Mongolian, has the effects of relieving cough and asthma, clearing heat and eliminating phlegm, and is clinically mainly used for treating chronic cough due to lung heat, dyspnea and excessive phlegm, chest fullness and oppression and chest pain.
Disclosure of Invention
In view of the above, it is necessary to provide a Chinese medicinal composition derived from the theory of traditional Chinese medicine, summarizing multiple clinical experiences, and developing and utilizing active substances of some medicinal materials, and the present invention has been made.
The invention provides a traditional Chinese medicine composition for inhibiting airway inflammation, which is prepared from the following raw materials in parts by weight: 20 to 35 parts of fragrant solomonseal rhizome, 20 to 35 parts of lily, 20 to 35 parts of tuckahoe, 20 to 35 parts of kudzuvine root, 20 to 35 parts of manyflower solomonseal rhizome, 20 to 35 parts of reed rhizome, 20 to 30 parts of sea buckthorn, 20 to 30 parts of gordon euryale seed, 20 to 30 parts of moringa leaf, 20 to 30 parts of pine mushroom, 20 to 30 parts of raspberry, 20 to 30 parts of deer blood, 20 to 30 parts of deer whip, 20 to 30 parts of bull penis, 20 to 30 parts of saussurea involucrata culture, 20 to 30 parts of mulberry, 10 to 20 parts of chrysanthemum, 10 to 20 parts of nutmeg, 10 to 20 parts of walnut peptide, 10 to 20 parts of soybean peptide powder, 10 to 20 parts of wrinkled gianthyssop herb, 10 to 20 parts of medlar, 10 to 20 parts of orange peel, 10 to 20 parts of liquorice, 10 to 20 parts of hawthorn, 10 to 20 parts of substituted flower, 10 to 20 parts of sharpleaf galangal seed, 10 to 20 parts of hemp seed, 10 to 20 parts of 10 parts of hemp seed, 10 to 20 parts of wild jujube seed, 5 to 10 parts of donkey-hide gelatin, 1 to 5 parts of small red bean, 1 to 5 parts of sea cucumber, 1 to 5 parts of lotus seed, 1 to 5 parts of ginger and 1 to 5 parts of cinnamon.
Further, the raw materials also comprise 1 to 5 parts of internal ginseng and 1 to 5 parts of gynura procumbens according to parts by weight.
Further, the raw materials also comprise 1 to 5 parts of earthworm protein by weight, and the earthworm protein comprises 70 to 80 parts of lumbrokinase and 10 to 20 parts of fibrinolytic activator protein by weight.
The invention also provides a preparation method of the traditional Chinese medicine composition for inhibiting respiratory tract inflammation, which comprises the following steps:
s1, taking 20-35 parts by weight of fragrant solomonseal rhizome, 20-35 parts by weight of lily, 20-35 parts by weight of poria cocos, 20-35 parts by weight of kudzuvine root, 20-35 parts by weight of rhizoma polygonati, 20-35 parts by weight of reed rhizome, 20-30 parts by weight of sea buckthorn, 20-30 parts by weight of gorgon euryale seed, 20-30 parts by weight of moringa leaves, 20-30 parts by weight of matsutake, 20-30 parts by weight of raspberry, 20-30 parts by weight of deer blood, 20-30 parts by weight of deer penis, 20-30 parts by weight of bull penis, 20-30 parts by weight of saussurea involucrata culture and 20-30 parts by weight of mulberry, adding water with the weight of 20-40 times for decoction, filtering, concentrating and drying the filtrate for later use;
s2, taking 10-20 parts of chrysanthemum, 10-20 parts of nutmeg, 10-20 parts of walnut peptide, 10-20 parts of soybean peptide powder, 10-20 parts of agastache rugosus, 10-20 parts of medlar, 10-20 parts of orange peel, 10-20 parts of liquorice, 10-20 parts of hawthorn, 10-20 parts of bitter orange, 10-20 parts of fructus alpiniae oxyphyllae, 10-20 parts of fructus cannabis, 10-20 parts of fructus amomi, 10-20 parts of spina date seed, 1-5 parts of red bean, 1-5 parts of sea cucumber, 1-5 parts of galangal, 1-5 parts of lotus seed, 1-5 parts of honey and 1-5 parts of cinnamon, adding 5-10 times of water for decoction, filtering, concentrating and drying the filtrate for later use;
And S3, mixing 5-10 parts by weight of donkey-hide gelatin with the concentrate obtained in the step S1 and the step S2, adding 50-100 times of water by mass of the mixture, heating to not higher than 45 ℃, dissolving, standing for more than 24 hours, and removing the supernatant to obtain the precipitate, namely the traditional Chinese medicine composition.
Further, 1 to 5 parts by weight of internal ginseng and 1 to 5 parts by weight of gynura procumbens are added in the step S2.
Furthermore, 1-5 parts of earthworm protein is added in the step S3.
The invention also provides application of the traditional Chinese medicine composition in preparation of anti-respiratory inflammation medicines.
Specifically, the inflammation is inflammation caused by a biological pathogen and/or a non-biological pathogen agent, the biological pathogen including at least one of bacteria, fungi, viruses, mycoplasma, chlamydia, legionella, rickettsia, and pneumocystis carinii.
Compared with the prior art, the invention has at least the following technical effects:
the invention is based on commonly accepted respiratory tract inflammation, a normal group, a model group, a control group and an experimental group are arranged, the central composition and western medicine methoxynamine capsules provided by the invention are administrated under a mouse model with lung yin deficiency syndrome, and then the expression conditions of inflammatory cytokines of the bodies of all groups of mice in blood, bronchoalveolar lavage fluid and lung tissues are detected respectively, so as to discuss the correlation between cough and respiratory tract inflammation of mice with lung yin deficiency syndrome and the influence of the traditional Chinese medicine composition provided by the invention on the expression of systemic and local inflammatory factors in the treatment of lung yin deficiency syndrome. The result shows that the traditional Chinese medicine composition provided by the invention can control cough through a method of inhibiting respiratory tract inflammation by means of reasonable formula of special medicinal materials and dialectical regulation, and the pathogenesis of chronic cough with lung-yin deficiency syndrome in traditional Chinese medicine is proved to be related to respiratory tract inflammation.
Drawings
Fig. 1 is a graph of pathological section of pulmonary inflammation of mice (a normal group, B model group, C control group, D experimental group (example 1)) provided by the animal experiment of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention will be described in further detail with reference to the following examples. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention.
Traditional Chinese medicine composition and preparation method thereof
The invention provides a traditional Chinese medicine composition which is prepared from the following raw materials in parts by weight: 20 to 35 parts of fragrant solomonseal rhizome, 20 to 35 parts of lily, 20 to 35 parts of tuckahoe, 20 to 35 parts of kudzuvine root, 20 to 35 parts of manyflower solomonseal rhizome, 20 to 35 parts of reed rhizome, 20 to 30 parts of sea buckthorn, 20 to 30 parts of gordon euryale seed, 20 to 30 parts of moringa leaf, 20 to 30 parts of pine mushroom, 20 to 30 parts of raspberry, 20 to 30 parts of deer blood, 20 to 30 parts of deer whip, 20 to 30 parts of bull penis, 20 to 30 parts of saussurea involucrata culture, 20 to 30 parts of mulberry, 10 to 20 parts of chrysanthemum, 10 to 20 parts of nutmeg, 10 to 20 parts of walnut peptide, 10 to 20 parts of soybean peptide powder, 10 to 20 parts of wrinkled gianthyssop herb, 10 to 20 parts of medlar, 10 to 20 parts of orange peel, 10 to 20 parts of liquorice, 10 to 20 parts of hawthorn, 10 to 20 parts of substituted flower, 10 to 20 parts of sharpleaf galangal seed, 10 to 20 parts of hemp seed, 10 to 20 parts of 10 parts of hemp seed, 10 to 20 parts of wild jujube seed, 5 to 10 parts of donkey-hide gelatin, 1 to 5 parts of small red bean, 1 to 5 parts of sea cucumber, 1 to 5 parts of lotus seed, 1 to 5 parts of ginger and 1 to 5 parts of cinnamon.
Further, the raw materials also comprise 1 to 5 parts of internal ginseng and 1 to 5 parts of gynura procumbens according to parts by weight. Furthermore, the raw materials also comprise 1 to 5 parts of earthworm protein by weight, specifically, the earthworm protein comprises 70 to 80 parts of lumbrokinase and 10 to 20 parts of fibrinolytic activator protein by weight.
Rhizoma Polygonati Odorati, academic name: polygonatum odoratum (Mill.) Druce is a perennial herb of the family Liliaceae. The rootstalk is transversely moved, the meat quality is yellow-white, and most fibrous roots are densely grown. Green leaf surface, grey below. Axillary flowers usually grow in 1 to 3 clusters. The original southwest area of China has wide wild distribution. The soil is cold-resistant, also resistant to yin, is good for moist environment, and is suitable for growing in loose soil rich in humus. The stems of the cloud of the materia medica concentrated injection are strong and straight, similar to a bamboo arrow shaft, and have knots. So it has the name of Yuzhu. The rhizome of the plant can be used for medicine, the traditional Chinese medicine is also named as fragrant solomonseal rhizome, and is picked in autumn, cleaned, dried to be soft, repeatedly rubbed, dried to be free of hard cores, dried in the sun, or steamed, kneaded to be semitransparent, dried in the sun, and cut into thick slices or sections for use. The polygonatum contains polysaccharide POA-70S, which is obtained after hydrolysis for 2 hours by 0.5M concentrated sulfuric acid, fructose, a small amount of glucose, fucose and mannose are mainly present in the POA-70S, the mass fraction ratio is 69.05:3.85:2.65:0.3, and the solid morphology is mainly in a smooth sheet amorphous state. POA-70S contains residues such as Fruf- (2. Fwdarw., D-Glcp- (1. Fwdarw.,. Fwdarw.6) -Fruf- (2. Fwdarw., 2) -Fruf- (1. Fwdarw. Glycosidic bond, etc.
Lily, the academic name Lilium brown var. Viridum Baker, the other name of Qiangshu, chinese chives, shandan, daphne, ganmai, moluo, heavy boxes, zhongjinghua, lily garlic, master garlic, garlic brain potato, night-time flower and the like, is a perennial herbal bulb plant of the genus Lily of the family Liliaceae, is native to China, is mainly distributed in northern hemisphere temperate regions such as Asian east, europe, north America and the like, and has been found to be at least 120 varieties worldwide, wherein 55 varieties are produced in China. In recent years, more new varieties are produced by artificial hybridization, such as Asian lily, perfume lily, fire lily and the like. The bulb contains rich starch, and is edible and also used as medicine.
Poria, also known as YULING, FULING, mo Linggui, FUZHONG. Gorgon fruit is dry sclerotium of Poria cocos (Willd.) of Folum of Folum Papaveraceae, and is usually parasitic on pine root, such as sweet potato, spherical, pale brown or black brown, and white or pink inside, and is called Poria or Poria after refining; can be used for treating dysuria, edema, phlegm retention, cough, vomiting, lochia, diarrhea, spermatorrhea, stranguria, palpitation, and amnesia.
The root of kudzu vine is the dried root of Pueraria lobata (Willd.) Ohwi of Leguminosae, and is known as Pueraria lobata (Willd.) Ohwi. Digging in autumn and winter, and cutting into thick or small pieces; and (5) drying. Sweet, pungent and cool. Has the effects of relieving muscle and fever, promoting eruption, promoting fluid production to quench thirst, and raising yang to check diarrhea. It is commonly used for exterior syndrome with fever, pain in the neck and back, measles, thirst due to fever, diabetes due to yin deficiency, diarrhea due to heat-purging, spleen deficiency, diarrhea.
Rhizoma polygonati, school name: polygonatum sibiricum, also known as: rhizoma polygonati, yellow chicken dish, pennywort herb, radix polygonati officinalis, rhizoma zingiberis, and radix polygonati officinalis. Is a Polygonatum plant, the rhizome is transverse, cylindrical and the nodule is enlarged. She Lunsheng, no handle. The medicinal plant has effects of invigorating spleen, moistening lung and promoting salivation.
Reed rhizome, reed head and reed root are produced in river, lake, pond, ditch, coast and low-humidity land. Is also a name of traditional Chinese medicine, and is used for treating pyretic disease, polydipsia, gastric heat vomiting, cough due to lung heat, and pus vomiting due to pulmonary abscess, and stranguria due to heat.
Sea buckthorn, school name: hippophae rhamnoides Linn is a deciduous shrub, which is drought-resistant and wind-sand resistant, and can survive on salinized lands, and is therefore widely used for water and soil conservation. Sea buckthorn is planted in great quantity in northwest of China and is used for desert greening. The root, stem, leaf, flower and fruit of Hippophae rhamnoides, especially the fruit of Hippophae rhamnoides, contains abundant nutrients and bioactive substances. The fructus Hippophae has effects of relieving cough, resolving phlegm, invigorating stomach, resolving food stagnation, promoting blood circulation, and removing blood stasis.
Gorgon fruit, school name: euryale ferox, salisb.ex Konig et Sims, annual aquatic herbs of Gordon genus of Nymphaeaceae. The submerged arrow-shaped or oval kidney-shaped, the floating water She Gezhi, oval kidney-shaped to round, thick and strong petioles and pedicel, and purple inner surface of the flower; sepal needle-like, petal purplish red rectangular round needle-like or needle-like, berry ball-like, dirty purplish red, seed ball-like, black. Flowering for 7-8 months and fruiting for 8-9 months. Semen euryales has effects of invigorating kidney, stopping nocturnal emission, invigorating spleen, relieving diarrhea, eliminating dampness, and stopping leukorrhagia, and can be used for treating nocturnal emission, spermatorrhea, enuresis, frequent urination, spleen deficiency chronic diarrhea, white turbidity, and leukorrhagia.
The moringa oleifera leaf refers to the leaf of a perennial tropical deciduous arbor moringa tree (also called drumstick tree) native to India, is edible, has the effects of comprehensively supplementing nutrition, improving immunity, expelling toxin, beautifying, promoting bowel movement, reducing weight and the like, and is rich and comprehensive in nutrition, and vitamin E is 70 times and 40 times of that of spirulina and soybean powder respectively.
Tricholoma matsutake, named Tricholoma matsutake, armillariella matsutake, syzygium, and Thermomyces, belonging to Basidiomycotina and Tricholomataceae, is mycorrhizal fungi of tree exogenesis such as Tricholoma matsutake, has unique aromatic flavor, is rare and precious natural medicinal fungus in the world, contains various active substances unique to Tricholoma matsutake, and is widely used internationally for preparing medicines, health products and cosmetics.
Raspberry (academic name: rubus idaeus l.) is a woody plant of genus Rubus of family rosaceae, is a fruit, has sweet and sour taste, and has barbed needles on the branches. Raspberries have many aliases, for example: raspberry, wild strawberry, raspberry and Wuzi. The raspberry fruits are a kind of polymerized fruits, red, golden and black, are widely distributed in China but rarely known as fruits in Europe and America, have a small amount of cultivation in northeast, and are relatively rare in the market. The raspberry plant can be used as medicine, has various medicinal values, and has the effects of tonifying kidney and strengthening yang. The raspberry oil belongs to unsaturated fatty acid, and can promote hormone secretion of prostate.
Deer blood is blood of Cervus Nippon Temminck and Cervus Nippon Temminck of Cervidae, and is a rare traditional Chinese medicine. Since ancient times, palace imperial palace and dasense show precious diseases treating and body building precious products, and a compound product mainly comprising the palace imperial palace and dasense is called a Xianjia food Danfang. Animal experiments and clinical researches prove that deer blood has a plurality of treatment and health care effects of maintaining beauty, treating anemia, regulating immunity, delaying aging, improving memory, resisting fatigue, improving sexual function and the like.
Penis et testis Cervi, the name of Chinese medicine, also called penis et testis Cervi, and penis et testis Cervi. Is male external genitalia of Cervus Nippon Temminck or Cervus Nippon Temminck of Cervidae. After slaughtering deer, cutting penis and testis, removing residual meat and grease, and fixing on wood board for air drying. It is preferable to be coarse, oily, free of residual meat and grease, free of worm-eating and dry. "Sichuan traditional Chinese medicine Zhi": warm nature, salty and spicy taste, no toxicity; enter three meridians of liver, kidney and bladder; for impotence, tinnitus due to kidney deficiency, cold womb, infertility, and chronic testis inflammation. However, the plain body Yang Chengzhe should be taken with cautions. The penis et testis Cervi is convenient to use, and can be soaked in wine to make medicated diet, or be boiled for food, or be decocted into paste, or be made into pill or powder.
The bull penis is the external genitalia of male cattle, is also called Niu Chong, is rich in androgens, proteins and fat, can tonify kidney and strengthen yang, is mainly used for treating symptoms such as impotence, spermatorrhea, soreness and weakness of waist and knees and the like of kidney deficiency, has the collagen content of up to 98 percent, and is also a preferred good product for female beauty.
Saussurea involucrata is a rare Chinese medicine which is endangered and has very scarce resources. A large amount of saussurea involucrata cell cultures can be obtained in a short period by using the cell in-vitro culture technology, and the drug effect substances which are the same as those of plant saussurea involucrata can be theoretically generated, so that the culture medium becomes a substitute resource of natural saussurea involucrata. The saussurea involucrata culture is a technology that plant organs, tissues, cells, embryos or protoplasts of saussurea involucrata are cultured on a culture medium prepared manually under the aseptic condition, and the culture is carried out under the manual control condition, so that the tissues or the cells are added and then are cultured according to the requirement; or by dedifferentiating it to give callus, and gradually differentiating the organ again to give a whole plant. The saussurea involucrata cell culture comprises a plurality of compounds such as simple phenylpropanoids, coumarins, lignans, alkaloids, terpenes, flavonoids, steroids and the like.
Mulberry, a near-ripe dried ear of Morus alba (Morusalba) of Moraceae. Has cold nature and sweet taste, and has effects in nourishing liver, invigorating kidney, nourishing yin and blood, and can be used for treating giddiness, tinnitus, palpitation, insomnia, constipation due to intestinal dryness, etc. The main components include sugar, tannic acid, malic acid, carotene, vitamins B1, B2, C, etc., and has the functions of enhancing immunity and stimulating lymphocyte transformation.
Chrysanthemum, school name: dendranthema morifolium Tzvelev, which is perennial root herb of Compositae, chrysanthemum in plant taxonomy, has effects of dispelling pathogenic wind, suppressing hyperactive liver, and is effective in treating common cold and headache.
Nutmeg, academic name: myristica fragrans it is an evergreen arbor plant of Myristica of Myristicaceae. Small arbor; the young branches are slender. The plant is a tropical and well-known spice and medicinal plant. Collected in winter and spring when the fruits are ripe. The kernel can be used as medicine for treating diarrhea, cold dysentery, stomach and abdomen crymodynia, emesis, etc.; it can be used as parasite repellent for external application to treat rheumatalgia. In addition, the product can be used as flavoring agent, industrial oil raw material, etc. Mylar is an important spice, medicinal plant.
The walnut peptide is small molecular peptide extracted by taking walnut protein as a raw material and adopting a directional biological enzyme digestion technology and a low-temperature membrane separation technology. The walnut peptide is rich in 8 amino acids necessary for human body, is a novel nutrient substance, has good nutrition characteristics, and is a promising and safe functional food raw material.
The soybean peptide powder is a mixed peptide product which consists of 2-6 amino acids and has a molecular weight of 200-800 Dalton. Compared with the original protein, the soybean peptide powder has good water solubility, water retention and foamability, and can be completely dissolved under any acid-base condition with pH of 2-10. The soybean peptide powder can be completely dissolved with other food ingredients, and maintains the original physical and chemical characteristics and nutrition characteristics of the soybean peptide powder.
Wrinkled giant hyssop, the academic name: agastache rugosa (fischer. Et mey.) o.ktze; also known as: the plant is a perennial herb of the genus Agastache of the order Labiatae, the stem is upright, 0.5-1.5 m high, quadrangular, 7-8 mm thick, oval in the shape of leaf heart to long round needle-like, the corolla is light purple blue, 8mm long, the mature small nut egg is long round, 1.8mm long, 1.1mm wide, 6-9 months in flowering phase and 9-11 months in fruiting phase. Its nature and flavor are pungent and slightly warm. Enter spleen, stomach and lung meridians.
Fructus Lycii is mature fruit of Lycium barbarum of Solanaceae. Picking the ripe summer and autumn fruits, removing the fruit stalks, airing in a shade until the fruit peel is wrinkled, and then insolating until the outer skin is dry and hard and the pulp is soft. Can be dried by using slow fire in the presence of rain. Fructus Lycii has various health promotion effects, and is a food approved by Ministry of health for both medicine and food. Proper amount of the tea is beneficial to health, and the tea has the effects of clearing liver and improving vision when being matched with chrysanthemum and wolfberry tea.
Orange peel and Chinese medicine name. Is dried mature pericarp of Rutaceae plant orange Citrus reticulata Blanco and its cultivar. The medicinal materials are divided into dried orange peel and dried orange peel. Picking ripe fruits, peeling off peel, sun drying or low temperature drying, regulating qi-flowing, invigorating spleen, eliminating dampness and resolving phlegm.
Licorice root, school name: glycyrrhiza uralensis Fisch, alias: lao, sweet grass, ural Glycyrrhrizae radix, and sweet root. The roots and rhizomes of the perennial herbs of the leguminous plants and the liquorice are thick and strong, and the liquorice is a tonic Chinese herbal medicine. The medicinal part is root and rhizome, the shape of the root is cylindrical, the length is 25-100 cm, and the diameter is 0.6-3.5 cm. The skin has different tightness, and the surface is reddish brown or grey brown. The rhizome is cylindrical, the surface is provided with bud marks, and the middle part of the section is provided with marrow. Slight smell, sweet and special taste. The functions of the medicine are mainly clearing heat and detoxicating, eliminating phlegm and relieving cough, and the like. A dry climate with long sunlight and low air temperature. Licorice is used for medical use in arid and semiarid desert grasslands, desert edges and loess hilly areas.
Hawthorn fruit, crataegus pinnatifida Bunge, also known as mountain fruit, mountain red, rosaceae Hawthorn genus, deciduous tree, up to 6 meters. Hard core, thin pulp, slightly sour and astringent taste. The dried fruit can be eaten raw or used as a preserved fruit cake, can be used as a medicine after being dried, is a special tree seed for Chinese medicinal fruits, has the effects of reducing blood fat, blood pressure, strengthening heart, resisting arrhythmia and the like, is also a good medicine for strengthening spleen, stimulating appetite, resolving food stagnation, promoting blood circulation and reducing phlegm, and has good curative effects on chest, diaphragm, spleen fullness, hernia, blood stasis, amenorrhea and the like. The flavonoid vitexin in haw is one kind of anticancer medicine with high anticancer effect and its extract has certain effect in inhibiting cancer cell growth, proliferation and infiltration metastasis.
Substituted flowers, school name: citrusaurantuml.var. Lime, citrus aurantium. Belongs to Rutaceae and Citrus plants. The whole herb of the sedum aizoon contains various components of cardiac glycoside and non-cardiac glycoside, which are found in the medicine and food of many countries. The Chinese medicine is called as Fushou grass. It has effects in tonifying heart, promoting urination, tranquilizing mind, and slowing down heart rate, and can be used for treating acute and chronic cardiac insufficiency.
Fructus Alpinae Oxyphyllae is a dry mature fruit of plants of Zingiberaceae, and is collected in summer and autumn when the fruit turns from green to red. The fructus Alpinae Oxyphyllae contains volatile oil, wherein the main components of the volatile oil are sesquiterpenes such as eucalyptol, gingerol, and the like, and the volatile oil contains abundant vitamin B and vitamin C, and trace elements such as manganese, zinc, potassium, sodium, calcium, magnesium, phosphorus, iron, copper, and the like. Fructus alpiniae oxyphyllae warms spleen to check diarrhea and takes in saliva, warms kidney to arrest spontaneous emission and urinates. Can be used for treating diarrhea due to cold in spleen, cold pain in abdomen, excessive saliva and saliva, enuresis due to kidney deficiency, frequent urination, spermatorrhea, and turbid urine.
Fructus Cannabis is dry mature seed of Cannabis sativa L of Moraceae, and is also called fructus Cannabis, and fructus Cannabis. Hemp is cultivated in most areas of China, and is good in warm and moist climate, and has low requirements on soil, and is suitable for sandpaper soil or clay soil with deep soil layer, looseness, fertility and good drainage. Harvesting in autumn, removing impurities, and sun drying to obtain fructus Cannabis. Fructus Cannabis is sweet in taste and flat in nature, enters spleen, stomach and large intestine meridians, and has the effects of relaxing bowel, moistening dryness and killing parasites, and is clinically named as fructus cannabis and fried fructus cannabis. Fructus cannabis is sweet in taste and neutral in nature. Spleen, stomach and large intestine channels; has effects in loosening bowel to relieve constipation and nourishing. Sheng Huo Ma ren is good at loosening bowel to relieve constipation.
Fructus Amomi, school name: amomum villosum Lour is a perennial herb of the genus Amomum of the family Zingiberaceae, and has effects of activating qi-flowing, regulating middle warmer, regulating stomach, and activating spleen. For abdominal pain, distention, gastric stasis, dysphagia, vomiting, cold diarrhea, cold dysentery, fetal movement in pregnancy.
Semen Ziziphi Spinosae and Chinese medicinal herbs. Is a dry mature seed of Rhamnaceae plant Zizyphus jujuba Mill. Var. Spinosa (Bunge) Huex H.F.Chou, has effects of nourishing heart and liver, tranquilizing mind, arresting sweating, promoting salivation, and is commonly used for dysphoria with dysphoria, palpitation with dreaminess, asthenia, excessive sweat, body fluid injury, and thirst.
Donkey-hide gelatin, known as Chinese medicine, is a gel prepared by soaking and dehairing the skin of donkey Equus asinus L. Of Equus of Equaceae, and decocting. Is mainly used for treating various symptoms of blood deficiency, bleeding, lung yin deficiency, dry cough, yin injury, vexation, insomnia, yin deficiency, wind-power, and convulsion of hands and feet. Donkey-hide gelatin is mostly composed of bone collagen, and is hydrolyzed to obtain various amino acids such as lysine, arginine, histidine, cystine, tryptophan, hydroxyproline, aspartic acid, threonine, serine, glutamic acid, proline, glycine, alanine, etc. Whereas collagen is non-fibrillar collagen, the α -chain of which contains both triple-helical domains (collagen domains, COL) and non-triple-helical domains (non-collagen domains, NC), wherein fibrillar collagen accounts for about 90% of the total collagen. Specifically, the donkey-hide gelatin provided by the invention is bone collagen of non-fibrous collagen.
The red bean, also called red bean, red bean and Zhu Dou, is mature seed of annual semi-winding herbaceous plant red bean of leguminous plant, cultivated in all regions of the country, harvested when summer and autumn pods are mature, sun-dried and the seed is collected for standby. Seeds are used for eating; the medicine has the effects of promoting blood circulation, tonifying blood, strengthening spleen, removing dampness, inducing diuresis and relieving edema.
Sea cucumber belongs to the class of invertebrate, echinoderm, and sea cucumber. The sea cucumber extract not only contains more than 50 nutrient components required by human bodies such as amino acids, vitamins, chemical elements and the like, but also contains various bioactive substances such as acidic mucopolysaccharide, saponin, collagen and the like, and the pharmacological activity of the sea cucumber active substances is very wide.
Galangal, school name: alpinia officinarum Hance it is a plant of the genus Alpinia of the family Zingiberaceae. Perennial herbs have root-shaped stems with plant heights of 40-110 cm, and have prolonged rhizome and cylindrical shape. The blade is linear, and has a length of 20-30 cm and a width of 1.2-2.5 cm. The total inflorescence grows on top, stands upright, and grows 6-10 cm, and the inflorescence axis is fluffed. The fruit is spherical, has a diameter of about 1 cm, and is red when cooked. Its rhizome is used for medicine, and has the functions of warming middle-jiao, dispelling cold, relieving pain and promoting digestion.
Lotus seed, the name of traditional Chinese medicine, is the dried mature seed of lotus Nelumbo nucifera Gaertn. Distributed in the south and north provinces of China. Has effects of invigorating spleen, relieving diarrhea, stopping leukorrhagia, invigorating kidney, astringing essence, nourishing heart, and tranquilizing. It is often used for diarrhea due to spleen deficiency, leukorrhagia, spermatorrhea, palpitation and insomnia.
Honey is a natural sweet substance obtained by fully brewing honey from flowers of flowering plants in honeycomb. The flavor is fragrant and rich, the taste is pure and sweet, and the tea is rich in various vitamins, minerals and amino acids.
Cinnamon, school name: cinnamomum cassia Presl the bark of a medium-sized arbor of the genus Cinnamomum belonging to the family Lauraceae is grey brown. The leaves are mutually grown or nearly grown, the shape of an oblong to nearly needle-shaped, the shape of a leather, the edge of a soft bone, the inner roll, the green, the luster, the no hair and the thick and strong petiole. Axillary or near-acrogenesis of panicles. Cinnamon has the functions of warming middle energizer and tonifying kidney, dispelling cold and relieving pain, and is used for treating cold pain in waist and knee, deficiency cold stomach pain, chronic dyspepsia, abdominal pain, vomiting and diarrhea, and cold-affected amenorrhea.
The fleshy root of ginseng is a famous tonic, is suitable for regulating blood pressure, restoring heart function, neurasthenia, and asthenia, and has the effects of eliminating phlegm, invigorating stomach, promoting urination, and exciting.
The gynura procumbens has the school name Gynura procumbens (Lour.) Merr. Belonging to the family Compositae, wherein gynura climbing herbs have odor, stem creeping, ribbing and branching; she Jubing; oval, oval or elliptical, full-edged or wavy teeth, arc-shaped side veins, unobvious thin veins, green upper surface, purple lower surface, hairless two surfaces, hairless petiole, acrogenesis or axillary umbrella inflorescence, slender inflorescence peduncles, normal linear bracts, bracts in a narrow shape or a funnel shape, long round needles in the shape of the bracts, orange yellow flowers; the corolla tube is thin, split egg-shaped, needle-shaped, the anther base is blunt, the clenbuterol is cylindrical, chestnut brown, the crown hair is rich, white and silk hair is thin. The fresh leaves and tender stems and leaves are rich in nutrition, and are green food for supplementing calcium for middle-aged and elderly people. The leaves can be eaten raw or fresh leaves are taken and soaked in boiled water to be served as tea, and the tea has the effects of clearing heat and detoxicating, stopping bleeding and relieving cough, promoting blood circulation and removing obstruction in collaterals, improving the immunity and antiviral capability of human bodies, supplementing calcium, resisting cold, reducing three highs, improving immunity and the like, and is a nontoxic-grade plant for both medicine and food.
The Lumbricus protein is extracted from Lumbricus, contains collagenase, plasmin, lumbrokinase, fibrinolytic activator protein (FA protein), nucleic acid, trace elements, etc., and has molecular weight of 5000-10000, and belongs to short chain small molecular substance. Lumbricus extract, lumbricus is extracted by high technology, and products such as Lumbricus protein tablet, lumbricus protein soft capsule, fibrinolytic activator protein, etc. have been successfully developed. Is widely used in clinic and increasingly used in the centers for preventing and treating diseases of heart, cerebral vessels, endocrine, respiratory system and the like. Lumbricus protein can be used for treating coagulation system and fibrinolysis system in vivo. Has wide influence, can obviously reduce the adhesion rate of the platelets of mice, prolong the in-vivo thrombosis and dissolve the in-vivo thrombus, increase the cerebral blood flow and reduce the cerebral vascular resistance. Improving microcirculation and reducing harm of three highs to human body.
The invention also provides a preparation method of the traditional Chinese medicine composition, which comprises the following steps:
s1, taking 20-35 parts by weight of fragrant solomonseal rhizome, 20-35 parts by weight of lily, 20-35 parts by weight of poria cocos, 20-35 parts by weight of kudzuvine root, 20-35 parts by weight of rhizoma polygonati, 20-35 parts by weight of reed rhizome, 20-30 parts by weight of sea buckthorn, 20-30 parts by weight of gorgon euryale seed, 20-30 parts by weight of moringa leaves, 20-30 parts by weight of matsutake, 20-30 parts by weight of raspberry, 20-30 parts by weight of deer blood, 20-30 parts by weight of deer penis, 20-30 parts by weight of bull penis and 20-30 parts by weight of mulberry, adding water which is 20-40 times by weight for decoction, filtering, concentrating and drying the filtrate for standby;
S2, taking 10-20 parts of chrysanthemum, 10-20 parts of nutmeg, 10-20 parts of walnut peptide, 10-20 parts of soybean peptide powder, 10-20 parts of medlar, 10-20 parts of orange peel, 10-20 parts of liquorice, 10-20 parts of hawthorn, 10-20 parts of fructus alpiniae oxyphyllae, 10-20 parts of fructus cannabis, 10-20 parts of spina date seed, 1-5 parts of red bean, 1-5 parts of sea cucumber, 1-5 parts of lotus seed, 1-5 parts of honey and 1-5 parts of cinnamon, adding 5-10 times of water for decoction, filtering, concentrating and drying filtrate for later use;
s3, mixing 5-10 parts by weight of donkey-hide gelatin, 20-30 parts by weight of saussurea involucrata culture, 10-20 parts by weight of agastache rugosus, 10-20 parts by weight of substituted flowers, 10-20 parts by weight of fructus amomi and 1-5 parts by weight of galangal with the concentrate obtained in the step S1 and the step S2, adding 50-100 times by weight of water, heating to not higher than 45 ℃, dissolving, standing for more than 24 hours, and discarding the supernatant to obtain the precipitate, namely the traditional Chinese medicine composition.
Further, 1 to 5 parts by weight of internal ginseng and 1 to 5 parts by weight of gynura procumbens are added in the step S2.
Further, 1 to 5 parts of earthworm protein is added in the step S3.
The traditional Chinese medicine composition provided by the embodiment of the invention can be applied to preparation of anti-respiratory inflammation medicines. Wherein the inflammation is an inflammation caused by a biological pathogen and/or a non-biological pathogen factor, the biological pathogen including at least one of bacteria, fungi, viruses, mycoplasma, chlamydia, legionella, rickettsia, and pneumocystis carinii.
The traditional Chinese medicine extract provided by the embodiment of the invention can be further respectively prepared into proper pharmaceutical dosage forms with one or more medicinal carriers such as auxiliary materials, excipients, diluents, solvents, stabilizers, disintegrants, flavoring agents, coloring agents, PH regulators, dispersing agents, isotonic agents and/or other additives. In preparing dosage forms comprising the medicament of the present invention, the traditional Chinese medicine extract or traditional Chinese medicine composition of the present invention is typically prepared with one or more pharmaceutically acceptable carriers by conventional mixing, dissolving, granulating, spindle-making grinding, emulsifying, encapsulating, entrapping or lyophilizing processes, and the like, wherein the active ingredient (the traditional Chinese medicine composition or traditional Chinese medicine extract) of the present invention is diluted or entrapped therein (see Remington's Pharmaceutical Sciences, fifteenth edition, hoover, j.e. major, mackpubishing co. (2003)).
The dosage forms may take any suitable form of administration, including topical, ocular, oral, systemic, nasal, injectable, transdermal, rectal, vaginal, etc., or inhalation or insufflation.
For topical administration, the medicament of the present invention may be formulated as a solution, gel, ointment, cream, suspension, or the like.
Systemic formulations include dosage forms for administration by injection, e.g., subcutaneous, intravenous, intramuscular, intrathecal or intraperitoneal injection, as well as dosage forms for transdermal, transmucosal oral or pulmonary administration.
Injectable dosage forms include sterile suspensions, solutions or emulsions of the drug of the invention in aqueous or oily vehicles.
The dosage form may also contain suspending, stabilizing and/or dispersing agents and the like. The injectable dosage forms may be provided in unit dosage forms, for example, in ampoules or in multi-dose containers, which may contain a preservative.
The injectable dosage form may also be selected in the form of a powder that is reconstituted prior to use with a suitable vehicle including, but not limited to, sterile, pyrogen-free water, buffers, dextrose solutions, and the like. The injectable dosage forms may be administered by direct intravenous injection, by intravenous bolus infusion, or by infusion by addition of an infusion solution such as 0.9% sodium chloride injection or other compatible infusion solutions.
For oral administration, the medicaments of the invention can be prepared in conventional manner using pharmaceutical excipients and/or additives into dosage forms such as tablets, tablets or capsules. Liquid dosage forms for oral administration may take the form of, for example, alcoholics, solutions, syrups or suspensions, or may be presented as a powder for constitution with water or other suitable vehicle before use. Such liquid dosage forms may be prepared by conventional means using pharmaceutical additives.
Formulations for oral administration may be formulated as controlled release dosage forms, the preparation processes and methods of which are well known in the art.
The pharmaceutical dosage form of the invention is preferably an oral dosage form or a parenteral dosage form. Oral dosage forms include tablets, capsules, troches, syrups, suspensions, powders and the like, with tablet and capsule dosage forms being preferred. Parenteral dosage forms include injectable forms, suppositories and sprays, preferably injectable injections, lyophilized powder injections, injectable solutions and the like.
The Chinese medicinal extract, chinese medicinal mixture or Chinese medicinal composition (hereinafter referred to as the "medicament of the invention") has at least one of anti-inflammatory, antipyretic, spasmolytic, antiasthmatic, antitussive, expectorant, immunity enhancing, antibacterial or antiviral effects, and can be used for treating at least one or more of cough, fever, dyspnea, hemoptysis, expectoration, shortness of breath, wheeze, chest pain and other clinical symptoms caused by various causes.
From the perspective of traditional Chinese medicine, the clinical symptoms related by the invention include high fever, no sweating but no resolution, cough and dyspnea, nasal flaring and qi coarseness, yellow and thick phlegm or rust colored phlegm, chest pain, thirst and dysphoria, yellow and red urine and dry stool. A red tongue with yellow coating and a slippery and rapid pulse or a rapid and rapid pulse.
The invention is further illustrated by the following examples. The examples are only for illustrating the implementation and effect of the present invention and are not intended to limit the present invention in any way. The traditional Chinese medicines, raw materials, excipients, diluents, auxiliary materials, reagents or other medicines mentioned in the following examples are commercially available products unless otherwise specified. Unless otherwise specified, "%" of the substances mentioned therein are% by weight and "parts" are parts by weight. To facilitate analysis of the specific embodiments of the present invention, the statistics are listed in table 1. In Table 1, the raw materials are rhizoma Polygonati Odorati, poria, fructus Hippophae, semen euryales, fructus Alpinae Oxyphyllae, fructus Cannabis, colla Corii Asini, ginseng radix, gynura procumbens, and Lumbricus protein. Wherein, the components of the earthworm protein are the weight wind ratio of lumbrokinase and fibrinolytic activator protein, and the comparative example 14 comprises 10 parts of collagenase.
The preparation method comprises the following steps:
the F1 method comprises the following steps:
s1, taking 20-35 parts by weight of fragrant solomonseal rhizome, 20-35 parts by weight of lily, 20-35 parts by weight of poria cocos, 20-35 parts by weight of kudzuvine root, 20-35 parts by weight of rhizoma polygonati, 20-35 parts by weight of reed rhizome, 20-30 parts by weight of sea buckthorn, 20-30 parts by weight of gorgon euryale seed, 20-30 parts by weight of moringa leaves, 20-30 parts by weight of matsutake, 20-30 parts by weight of raspberry, 20-30 parts by weight of deer blood, 20-30 parts by weight of deer penis, 20-30 parts by weight of bull penis, 20-30 parts by weight of saussurea involucrata culture and 20-30 parts by weight of mulberry, adding water with the weight of 20-40 times for decoction, filtering, concentrating and drying the filtrate for later use;
S2, taking 10-20 parts of chrysanthemum, 10-20 parts of nutmeg, 10-20 parts of walnut peptide, 10-20 parts of soybean peptide powder, 10-20 parts of agastache rugosus, 10-20 parts of medlar, 10-20 parts of orange peel, 10-20 parts of liquorice, 10-20 parts of hawthorn, 10-20 parts of bitter orange, 10-20 parts of fructus alpiniae oxyphyllae, 10-20 parts of fructus cannabis, 10-20 parts of fructus amomi, 10-20 parts of spina date seed, 1-5 parts of red bean, 1-5 parts of sea cucumber, 1-5 parts of galangal, 1-5 parts of lotus seed, 1-5 parts of honey and 1-5 parts of cinnamon, adding 5-10 times of water for decoction, filtering, concentrating and drying the filtrate for later use;
and S3, mixing 5-10 parts by weight of donkey-hide gelatin with the concentrate obtained in the step S1 and the step S2, adding 50-100 times of water by mass of the mixture, heating to not higher than 45 ℃, dissolving, standing for more than 24 hours, and removing the supernatant to obtain the precipitate, namely the traditional Chinese medicine composition.
In the method F2, 1 to 5 parts by weight of internal ginseng and 1 to 5 parts by weight of gynura procumbens are added in the step S2.
The F3 method is based on the F2 method, 1 to 5 parts of earthworm protein is added in the S3 step, and the earthworm protein comprises 70 to 80 parts of lumbrokinase and 10 to 20 parts of fibrinolytic activator protein by weight.
In addition, in the raw material column, the mass content of POA-70S in the polygonatum is also given in Table 1, and the mass content is shown in brackets of the polygonatum.
TABLE 1
Animal experiment
Animal experiments were performed on the Chinese medicinal compositions prepared in the above examples and comparative examples.
The mice used in this example were clean Balb/c male mice purchased from Jinan Pengyue laboratory animals breeding Co., ltd., production license number: SCXK (robust) 2019_0003.
Experimental grouping:
mice are randomly divided into a normal group, a model group, an experimental group and a control group according to a random number table, animals in each group are bred in cages, 5 mice are bred in each cage, wherein the experimental group comprises corresponding cages of examples 1-21 and comparative examples 1-17, water and food are freely drunk and eaten, an animal house is sterilized once every 3 days, constant temperature and humidity are kept, the animals are cleaned and sanitary every day, the animals are weighed for 1 time/week, records are made, and the administration dosage is readjusted according to the weight of the mice.
The molding method comprises the following steps:
mice in the model group, the experiment group and the control group are all infused with thyroxine powder 0.33g/100g and reserpine injection 0.6g/100g for 1d for 1 time, and the mice are put into a fumigating box for 1 week and are used for daily SO 2 The smoke was passively inhaled (concentration was kept at 90 mg/L) for 15min for 8 weeks.
The equivalent conversion of the liquid preparation and the administration dose of the mice is referred to the third edition of the traditional Chinese medicine pharmacological research methodology, which is mainly compiled by Chen Ji. All the medicines are fully dissolved in the existing preparation at present, the medicines are uniformly shaken and then irrigated to the stomach, the operation is gentle, unnecessary damage is avoided, the abnormal reaction of the mice is observed for 0.5h after the gastric lavage, and the record is made.
Animal administration:
the mice were given a daily equivalent dose of 1.4g/kg of body weight from the beginning of the molding of the experimental group. The control group was infused with the stomach according to 9mg/kg mice weight, and the powder was in the form of a compound methoxyna gelatin capsule. Distilled water is added into the 4 groups of medicines to prepare a solution according to the volume of l0 ml/kg. The normal group and the model group were filled with equal volumes of distilled water and continuously administered for 9 weeks.
And (3) detection: ELISA method is used for detecting the content of IL-6 and IL-17 in mouse serum and BALF (bronchopulmonary cell cleaning solution); the expression level of IL-6, IL-17 protein in the tissues was detected by Western-Blot.
Sample collection and cell count:
and after the last gastric lavage, fasting water for 12 hours, performing intraperitoneal injection on 10% of chloral hydrate according to the calculated dosage of the body weight, taking blood from abdominal aorta after the mice enter an anesthetic state, standing, centrifuging, separating serum, split charging, and immediately freezing for testing. The mice are placed on an operating table horizontally, the trachea and the heart and the lung are released and placed on the table, the right main bronchus is ligated, the trachea is inserted by using a venous indwelling needle catheter, and the trachea is ligated and fixed. The left lung is irrigated by bronchioalveolar with normal saline at 37 ℃, repeatedly pumped and pushed for 3 times, left for 1min, then pumped back and collected, repeated for 3 times, each time for 2ml, and each time the recovered liquid is filtered by two layers of sterile gauze and then is filled in a sterile centrifuge tube, and the recovery measurement (the recovery rate is about 85 percent qualified). Centrifuging at 1500rpm at 4deg.C for 10min, collecting supernatant, storing in refrigerator at-80deg.C for use, dripping BALF precipitation cells into 0.5ml PBS, re-suspending, collecting 20u1, and performing white blood cell count under hemocytometer; the cell smear of 30u1 lines was also taken, stained conventionally, and the percentages were determined by sorting and counting according to cell morphology under an optical microscope. Leave the right lung lower leaf tissue, cut into 1.5cm1X1.5cmX0.3 cm square small pieces, put in PE tube, frozen in-80 ℃ refrigerator for Western-Blot examination.
The data analysis method comprises the following steps:
the statistical method adopts SPSS 20.0 software to carry out statistical analysis, experimental data is expressed by (x+/-s), independent samples are adopted for comparison between two groups, the inspection is carried out, and single-factor variance analysis is adopted between multiple groups to carry out statistical analysis; the qualitative data is subjected to statistical analysis by using chi-square test; applying Pearson correlation analysis between the two variables; all data were statistically analyzed using SPSS 20.0, P <0.05 being statistically significant.
Table 2 cell counts and classification x±s, n=10 in BALF for each group of mice
Table 3 IL-6, IL-17 content x±s, n=10 in mouse serum
The lung inflammation pathological section of each group of mice is shown in figure 1. The bronchi, bronchioles and alveoli of the model group mice are contracted, the alveolar space is widened, inflammatory cells infiltrate into the wall and the lung interstitium, eosinophils are taken as the main materials, exudates are visible in the bronchi, bronchioles and alveoli, and the epithelium part of the bronchioles and bronchioles is necrotized and shed, and goblet cell hyperplasia is accompanied. The inflammatory response was significantly reduced in the experimental group (example 1) and the control group.
As can be seen from tables 2 and 3:
1. the difference of obvious increase of the white blood cell number in the normal group and the model group has obvious statistical significance, the percentage of neutrophils, lymphocytes and eosinophils in the model group obviously increases the ratio of macrophages to decrease, and the fact that inflammatory cell infiltration exists in the bronchoalveoli of the mice with the lung-yin deficiency syndrome proves that inflammatory reaction in the respiratory tract and bronchopulmonary tissues is one of the causes of chronic cough. In the normal group, serum IL-6 and IL-17 in the model group are obviously increased, which suggests that an inflammatory response exists in a lung yin deficiency type mouse model, wherein the IL-6 and IL-17 are obviously expressed in the inflammatory response of the organism.
2. The total number of white blood cells, eosinophils, neutrophils and lymphocytes in examples 1 to 22 in the control model group, the control group and the experimental group are obviously reduced, and macrophages of the control model group, the control group and the experimental group are obviously increased, so that the experimental group has the effect of inhibiting inflammatory reactions to different degrees. In the control model group, the control group and the experimental group in examples 1-22, the IL-6 and IL-17 in the serum of the mice are reduced to different degrees, which shows that the compound methoxynamine capsule and the traditional Chinese medicine composition provided by the invention have the effect of inhibiting the inflammatory reaction of organisms to different degrees.
3. In table 2, the donkey-hide gelatin of comparative example 1 uses fiber donkey-hide gelatin, the total white blood cell, eosinophil, neutrophil and lymphocyte ratio of which are all significantly higher than that of example 1, and the macrophage number is significantly lower than that of example 1, and there is no significant difference from the model group, and almost no effect of reducing inflammation. Similarly, in Table 3, the amounts of IL-6 and IL-17 expressed in the serum of the mice corresponding to comparative example 1 were significantly higher than those in example 1, and there was no significant difference from the model group, and almost no effect of reducing body inflammation. This shows that the non-fibrous donkey-hide gelatin is needed to be used in the formula of the traditional Chinese medicine composition to exert the efficacy.
4. In table 2, some or all of the corresponding Chinese medicinal compositions of comparative examples 2 to 12 were not within the scope of the present invention, resulting in significantly higher ratios of total white blood cells, eosinophils, neutrophils and lymphocytes than in example 1, significantly lower numbers of macrophages than in example 1, and no significant difference from the model group, and almost no reduction in inflammatory effects. Similarly, the amounts of IL-6 and IL-17 expressed in the serum of mice corresponding to comparative examples 2 to 12 were significantly higher than those in example 1, and there was no significant difference from the model group, and almost no effect of reducing body inflammation. The invention shows that the components in the traditional Chinese medicine composition need to be reasonably blended, and the respective effects are comprehensively exerted, so that the effect of inhibiting inflammation can be achieved.
5. In Table 2, the ratio of lumbrokinase to fibrinolytic activator in the additionally added lumbricus proteins of comparative examples 13 to 17 is not within the limited range, and the comparative example 17 further contains collagenase, which can degrade donkey-hide gelatin in the pharmaceutical composition, and these all result in significantly higher ratios of white blood cell count, eosinophil granulocyte, neutrophil granulocyte and lymphocyte than in example 18, and significantly lower number of macrophages than in example 18, and although some indexes are significantly different from the model group, the inflammation inhibition effect is not obvious. In Table 3, comparative examples 13 to 17 show the same tendency. The traditional Chinese medicine composition disclosed by the invention not only needs to adopt non-fibrous donkey-hide gelatin, but also can play a role in synergy for additionally regulated earthworm protein, but also cannot contain collagenase so as not to degrade the non-fibrous donkey-hide gelatin. The lumbrokinase has special affinity with fibrin, can track thrombolysis, improve microcirculation, and can generate affinity and dissolution effects on inflammatory factors when the trachea is stimulated, and the added donkey-hide gelatin can generate protective effect on the epithelial cells of the trachea mucosa during the degradation. The increased expression level of IL-6 in serum is related to the accelerated synthesis of C-reactive protein and fibrinogen by the liver, which leads to accelerated blood sedimentation, and the combination of lumbrokinase and donkey-hide gelatin can promote the dissolution of the fibrinogen to reduce blood sedimentation, thereby leading to the reduction of the expression level of the two internal inflammatory factors in serum.
6. In Table 2, example 10 showed a significant increase in POA-70S polysaccharide content in Polygonatum odoratum, relative to example 1, such that the total white blood cell count, eosinophil and neutrophil ratios were all significantly lower than example 1, while the macrophage count was significantly higher than example 1; example 22 compared to example 21, the POA-70S polysaccharide content in the rhizoma Polygonati Odorati was significantly increased, so that both lymphocytes and eosinophils were significantly reduced. The same trend is shown in table 3. This suggests that this particular polysaccharide in polygonatum odoratum produces protective effects on airway mucosal epithelial cells and degradation effects on inflammatory factors, and may also be involved in the regulation of TRPVi inflammatory signal pathways.
The most common causative factors of chronic cough are allergies, biological factors, cough air flow damage and chemical factors, these inflammatory factors can stimulate the production of inflammatory factors such as IL-17, IL-6, TNF and the like to mediate acute inflammatory reactions, IL-6 stimulates the liver to accelerate the synthesis of C-reactive proteins and fibrinogen, the latter accelerates blood sedimentation; IL-17 and TNF stimulate the synthesis of serum amyloid A by the liver and fixation while directly stimulating the thermoregulation centre. IL-6 and IL-17 have the effect of recruiting innate immune cells, resulting in local immune cytopenia, while secreting cytokines, resulting in the development of an immune inflammatory response. In the aspect of neurogenic airway inflammation, the TRPCvi expression of patients with chronic cough is obviously increased, and is positively correlated with airway hyperreactivity and airway remodeling degree. Part of scholars believe that the TRPVi pathway is the primary link in cough, and treatment of refractory chronic cough with TRPVi antagonists is a research hotspot, with significant antitussive effects on refractory chronic cough patients.
The research of the traditional Chinese medicine literature on chronic cough is mostly limited to verifying the treatment effect of a certain Chinese herbal medicine or compound on a certain single etiology. For symptoms of chronic cough patients, the traditional Chinese medicine can be dialectical to various different types, the cough mechanism of the traditional Chinese medicine needs to be researched by utilizing modern technology, and unified standards are established to be beneficial to research of evidence-based medicine so as to prove that the effectiveness of the traditional Chinese medicine is the way of development of the modern traditional Chinese medicine. But the related documents are few and the reliability is generally low.
The invention is based on commonly recognized airway inflammation, a normal group, a model group, a control group and an experimental group are arranged, the central composition and western medicine methoxynamine capsules provided by the invention are administrated under a mouse model with lung yin deficiency syndrome, and then the condition that inflammatory cytokines of the bodies of all groups of mice are respectively expressed in blood, bronchoalveolar lavage fluid and lung tissues is detected, so as to discuss the correlation between cough and airway inflammation of mice with lung yin deficiency syndrome and the influence of the traditional Chinese medicine composition provided by the invention on the expression of systemic and local inflammatory factors in the treatment of lung yin deficiency syndrome. The result shows that the traditional Chinese medicine composition provided by the invention can control cough through a method of inhibiting respiratory tract inflammation by means of reasonable formula of special medicinal materials and dialectical regulation, and the pathogenesis of chronic cough with lung-yin deficiency syndrome in traditional Chinese medicine is proved to be related to respiratory tract inflammation.
The present invention is not limited to the above-mentioned embodiments, and any changes or substitutions that can be easily understood by those skilled in the art within the technical scope of the present invention are intended to be included in the scope of the present invention.
Claims (7)
1. The traditional Chinese medicine composition for inhibiting respiratory tract inflammation is characterized by being prepared from the following raw materials in parts by weight: 20 to 35 parts of fragrant solomonseal rhizome, 20 to 35 parts of lily, 20 to 35 parts of tuckahoe, 20 to 35 parts of kudzuvine root, 20 to 35 parts of manyflower solomonseal rhizome, 20 to 35 parts of reed rhizome, 20 to 30 parts of sea buckthorn, 20 to 30 parts of gordon euryale seed, 20 to 30 parts of moringa leaf, 20 to 30 parts of pine mushroom, 20 to 30 parts of raspberry, 20 to 30 parts of deer blood, 20 to 30 parts of deer whip, 20 to 30 parts of bull penis, 20 to 30 parts of saussurea involucrata culture, 20 to 30 parts of mulberry, 10 to 20 parts of chrysanthemum, 10 to 20 parts of nutmeg, 10 to 20 parts of walnut peptide, 10 to 20 parts of soybean peptide powder, 10 to 20 parts of wrinkled gianthyssop herb, 10 to 20 parts of medlar, 10 to 20 parts of orange peel, 10 to 20 parts of liquorice, 10 to 20 parts of hawthorn, 10 to 20 parts of substituted flower, 10 to 20 parts of sharpleaf galangal seed, 10 to 20 parts of hemp seed, 10 to 20 parts of 10 parts of hemp seed, 10 to 20 parts of wild jujube seed, 5 to 10 parts of donkey-hide gelatin, 1 to 5 parts of small red bean, 1 to 5 parts of sea cucumber, 1 to 5 parts of lotus seed, 1 to 5 parts of ginger and 1 to 5 parts of cinnamon.
2. The Chinese medicinal composition according to claim 1, wherein the raw materials further comprise 1-5 parts by weight of ginseng and 1-5 parts by weight of gynura procumbens.
3. The traditional Chinese medicine composition according to claim 1 or 2, wherein the raw materials further comprise 1-5 parts by weight of earthworm protein, and the earthworm protein comprises 70-80 parts by weight of lumbrokinase and 10-20 parts by weight of fibrinolytic activator protein.
4. The preparation method of the traditional Chinese medicine composition for inhibiting respiratory tract inflammation is characterized by comprising the following steps:
s1, taking 20-35 parts by weight of fragrant solomonseal rhizome, 20-35 parts by weight of lily, 20-35 parts by weight of poria cocos, 20-35 parts by weight of kudzuvine root, 20-35 parts by weight of rhizoma polygonati, 20-35 parts by weight of reed rhizome, 20-30 parts by weight of sea buckthorn, 20-30 parts by weight of gorgon euryale seed, 20-30 parts by weight of moringa leaves, 20-30 parts by weight of matsutake, 20-30 parts by weight of raspberry, 20-30 parts by weight of deer blood, 20-30 parts by weight of deer penis, 20-30 parts by weight of bull penis and 20-30 parts by weight of mulberry, adding water which is 20-40 times by weight for decoction, filtering, concentrating and drying the filtrate for standby;
s2, taking 10-20 parts of chrysanthemum, 10-20 parts of nutmeg, 10-20 parts of walnut peptide, 10-20 parts of soybean peptide powder, 10-20 parts of medlar, 10-20 parts of orange peel, 10-20 parts of liquorice, 10-20 parts of hawthorn, 10-20 parts of fructus alpiniae oxyphyllae, 10-20 parts of fructus cannabis, 10-20 parts of spina date seed, 1-5 parts of red bean, 1-5 parts of sea cucumber, 1-5 parts of lotus seed, 1-5 parts of honey and 1-5 parts of cinnamon, adding 5-10 times of water for decoction, filtering, concentrating and drying filtrate for later use;
S3, mixing 5-10 parts by weight of donkey-hide gelatin, 20-30 parts by weight of saussurea involucrata culture, 10-20 parts by weight of agastache rugosus, 10-20 parts by weight of substituted flowers, 10-20 parts by weight of fructus amomi and 1-5 parts by weight of galangal with the concentrate obtained in the step S1 and the step S2, adding 50-100 times by weight of water, heating to not higher than 45 ℃, dissolving, standing for more than 24 hours, and discarding the supernatant to obtain the precipitate, namely the traditional Chinese medicine composition.
5. The preparation method according to claim 4, wherein 1 to 5 parts by weight of ginseng and 1 to 5 parts by weight of gynura procumbens are further added in the step S2.
6. The method according to claim 4 or 5, wherein 1-5 parts of earthworm protein is added in the step S3.
7. Use of a traditional Chinese medicine composition according to any one of claims 1-3 or a traditional Chinese medicine composition prepared by the preparation method according to any one of claims 4-6 in the preparation of an anti-respiratory inflammation medicament.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310536971.7A CN116440245A (en) | 2023-05-13 | 2023-05-13 | Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310536971.7A CN116440245A (en) | 2023-05-13 | 2023-05-13 | Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116440245A true CN116440245A (en) | 2023-07-18 |
Family
ID=87133860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310536971.7A Pending CN116440245A (en) | 2023-05-13 | 2023-05-13 | Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116440245A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12426887B2 (en) | 2019-09-26 | 2025-09-30 | Universität Zürich | Left atrial appendage occlusion devices |
-
2023
- 2023-05-13 CN CN202310536971.7A patent/CN116440245A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12426887B2 (en) | 2019-09-26 | 2025-09-30 | Universität Zürich | Left atrial appendage occlusion devices |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5864252B2 (en) | Medicinal plant extract using smoked product and skin external preparation composition containing the same | |
| CN104799048A (en) | Feed capable of improving Truogx sinensis disease resistance, and preparation method thereof | |
| CN105614145A (en) | High-nutrient feed additive for meat pigeons and preparation method of feed additive | |
| KR100939906B1 (en) | Feed Additives for Fish Farming Using Herbal Extracts | |
| CN107156828A (en) | A kind of full nutrition formula food suitable for patients with inflammatory bowel | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN116440245A (en) | Traditional Chinese medicine composition for inhibiting airway inflammation, preparation method and application | |
| CN108208456A (en) | A kind of feed addictive for improving laying rate of laying hen and preparation method thereof | |
| CN104522661A (en) | Healthy buccal tablets containing honeysuckle extract and production method thereof | |
| CN104095269B (en) | Preparation of a pure natural elderberry seed fruit drink | |
| CN103656195A (en) | Traditional Chinese medicine composition for treatment of kidney deficiency and preparation method thereof | |
| CN106805235A (en) | A kind of full nutrition formula food suitable for respiratory disease patient | |
| KR101028073B1 (en) | A composition and method for producing a composition having the action and mechanism for improving blood circulation, activating each part of the body and enhancing immunity | |
| CN105211441A (en) | Red sage root leaf health-care tea of a kind of hypertension and hyperlipemia and preparation method thereof | |
| US11576943B2 (en) | Functional food composition having cranial nerve protection effect and blood flow improvement effect | |
| CN114099626A (en) | Multifunctional composition for human body health care and preparation method and application thereof | |
| CN104905032A (en) | Feed additive for preventing and treating hepatitis of truogx sinensis | |
| CN104784491A (en) | Traditional Chinese medicine preparation for treating salpingitis of laying hens and preparation method thereof | |
| CN109646665A (en) | Cortex Eucommiae clearing lung-heat anticancer solid tea and preparation method thereof | |
| CN109528984A (en) | A kind of cream formula and preparation method by smearing breast treatment mammary gland disease | |
| CN104799007A (en) | Chinese herbal medicine additive for enhancing disease resistance of Truogx sinensis and preparation method thereof | |
| CN105055597B (en) | Traditional Chinese medicine preparation for treating peacock gastroenteritis and production method thereof | |
| KR102632013B1 (en) | A composition containing herbs extract, and manufacturing method of the same | |
| CN113142429B (en) | Qi and blood tonifying beverage composition and preparation method thereof | |
| CN108070503A (en) | A kind of sealwort mulberry health-care wine and its production method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication |